DDIT3 and Cholestatic liver disease: Nonetheless, the fact that the EPA/DHA treatment efficiently reduces BiP and CHOP expression in the presence, and even in the absence, of UDCA is of particular clinical interest since ER-stress and ER-stress mediated apoptosis is a common feature of cholestatic liver diseases [33,34,35,36].